WE DON'T HAVE TIME TO WASTE
The brain cancer community can no longer afford to accept traditional funding models that rely on scheduled requests for proposals, pre-set submission deadlines and 8-12 month review processes. We simply cannot afford to wait for a cure, we must make it happen, and we need your help! Our determination to create impactful projects and serve as frontline explorers in this space comes from not only our professional dedication, but also from our own personal connections.
THIS IS PERSONAL TO US
While our entire staff has been touched by cancer in some way, three of our six team members have been personally impacted by brain cancer. Those personal connections create an environment where passion drives everything we do.
Brain Tumor Survivor
Co-Founder, Race for Hope - DC
Director of Development
WE ARE LOOKING AHEAD...AND THE FUTURE IS PROMISING
Brain cancer is not a one-size-fits-all disease and our path to treatments can't afford to be either. Our recent projects have demonstrated time and again that a "personalized" approach to research will be crucial in our efforts to find a cure. Genomic sequencing, vaccines and personalized therapeutics are the next evolution in research and we are excited to see these projects move forward.
In order to continue our advance toward a cure, we need your continued support today.
This past year, in partnership with Exosome Diagnostics and the University of California San Diego, we launched the Exosome Diagnostic Tool project. With more than a dozen institutions working together to collect brain tumor, spinal fluid and blood samples we have built the largest, multi-center collaborative the brain tumor community has ever seen. We sat down with Dr. Bob Carter, Chief of Neurosurgery, UCSD Medical Center and the head of the collaborative to hear from him on the promise of a personalized approach:
Dr. Bob Carter, Chief of Neurosurgery, UCSD Medical Center: The Future of Personalized Approaches
TOGETHER, WE WILL ACCELERATE THE CURE.
Our mission is to be the catalyst for change in the brain cancer research community and we strive to remain at the forefront of new discoveries. Thanks to the dedication of our supporters we are able to help engineer exciting projects and facilitate ground-breaking collaborations among academic researchers, biotechnology companies and the pharmaceutical industry. This approach stems from our belief that the path to new treatments will not be discovered by one mind working alone, but rather by many minds working as one. We know you trust us to be brave leaders in the creation of new research and therapeutics and we are proud of our many "firsts" that have pushed progress over the edge and inspired others to follow our lead: